List of Excipients in API ivacaftor
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ivacaftor
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | KALYDECO | ivacaftor | 51167-200 | AMMONIA | 2029-08-13 |
| Vertex Pharmaceuticals Incorporated | KALYDECO | ivacaftor | 51167-200 | CARNAUBA WAX | 2029-08-13 |
| Vertex Pharmaceuticals Incorporated | KALYDECO | ivacaftor | 51167-200 | CELLULOSE, MICROCRYSTALLINE | 2029-08-13 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ivacaftor
Excipient focus: AMMONIA
ivacaftor drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
ivacaftor drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ivacaftor drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
ivacaftor drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
ivacaftor drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
ivacaftor drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 06081224
ivacaftor drug variants containing HYPROMELLOSE ACETATE SUCCINATE 06081224
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 06081224
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
ivacaftor drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ivacaftor drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
ivacaftor drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
ivacaftor drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
ivacaftor drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
ivacaftor drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ivacaftor drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
ivacaftor drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
ivacaftor drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ivacaftor drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | ivacaftor | 51167-200 |
| >Company | >Ingredient | >NDC |
ivacaftor drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
